An injection given just twice a year could herald a breakthrough in protecting the population that has the highest infection rates.
Tag: Truvada (Drug)
Shot to Prevent H.I.V. Works Better Than Daily Pill in Women
Researchers ended a clinical trial of the drug early because the results were so convincing. The more effective drug would be given in six injections a year instead of as 365 daily pills.
Who Owns H.I.V.-Prevention Drugs? The Taxpayers, U.S. Says
In an unexpected lawsuit, federal officials claim that Gilead Sciences willfully disregarded government patents on medicines necessary to end the AIDS epidemic.
Someday, an Arm Implant May Prevent H.I.V. Infection for a Year
In preliminary tests, a matchstick-size rod containing a new drug offered promise as a shield against the virus. But a large clinical trial must still be done.
This Drug, Underused in the U.S., May Help Make H.I.V. Very Rare in Australia
The most recent advance in Australia’s decades-long fight against the virus is the rapid adoption of a preventive drug regimen known as PrEP.
Global Health: Gilead Will Donate Truvada to U.S. for H.I.V. Prevention
The manufacturer will provide enough of the drug to supply 200,000 patients annually for more than a decade. Critics said it would not be enough to end the AIDS epidemic and questioned the company’s motives.
Global Health: Bit by Bit, Scientists Gain Ground on AIDS
The “London patient,” apparently cured of H.I.V. infection, has gotten all the attention. But other recently revealed advances are more likely to affect the immediate course of the AIDS epidemic.